Phase II Randomized, Multicenter, Double-blind, Doubledummy, Parallel Clinical Trial to Evaluate the Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder
Latest Information Update: 27 Feb 2026
At a glance
- Drugs APSTZD-Apsen Farmaceutica (Primary) ; Zolpidem
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Apsen Farmaceutica
Most Recent Events
- 27 Feb 2026 New trial record